Header Logo

Connection

Mark Pollack to Endotoxins

This is a "connection" page, showing publications Mark Pollack has written about Endotoxins.
Connection Strength

0.147
  1. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core. J Clin Invest. 1983 Dec; 72(6):1874-81.
    View in: PubMed
    Score: 0.060
  2. Distinct functional activities in canine septic shock of monoclonal antibodies specific for the O polysaccharide and core regions of Escherichia coli lipopolysaccharide. J Infect Dis. 1994 Mar; 169(3):553-61.
    View in: PubMed
    Score: 0.030
  3. Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity. J Infect Dis. 1992 Jan; 165(1):34-45.
    View in: PubMed
    Score: 0.026
  4. Monoclonal antibodies that recognize epitopes in the core and lipid A region of lipopolysaccharides. Prog Clin Biol Res. 1988; 272:327-38.
    View in: PubMed
    Score: 0.020
  5. Development of an anti-idiotype monoclonal antibody mimicking the structure of lipopolysaccharide (LPS) inner-core determinants. Microb Pathog. 1993 Aug; 15(2):103-20.
    View in: PubMed
    Score: 0.007
  6. Circulating immune complexes in cystic fibrosis. Pediatr Res. 1980 Jun; 14(6):830-3.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.